ArticleVaccine2019

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

Hana M El Sahly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.